Nanalysis Scientific Corp.
NSCI.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -167.15% | 74.28% | 48.88% | 36.03% | 26.98% |
| Total Depreciation and Amortization | 128.32% | -58.86% | -61.90% | -60.64% | -13.06% |
| Total Amortization of Deferred Charges | -74.42% | -- | -- | -- | 0.33% |
| Total Other Non-Cash Items | 682.41% | -78.83% | 492.77% | 171.45% | 290.63% |
| Change in Net Operating Assets | 62.74% | -36.21% | 269.55% | 2,635.24% | 21.24% |
| Cash from Operations | 140.65% | 76.54% | 130.75% | 137.48% | 53.09% |
| Capital Expenditure | 100.00% | 2.22% | 99.55% | 87.72% | -167.11% |
| Sale of Property, Plant, and Equipment | 11,128.57% | -- | -- | -- | -103.52% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.05% | 55.35% | 75.71% | 46.87% | -79.54% |
| Cash from Investing | 80.61% | 68.55% | 79.50% | 57.05% | -189.03% |
| Total Debt Issued | -56.18% | -56.91% | -- | -- | 5.34% |
| Total Debt Repaid | -290.31% | 69.30% | 73.91% | -895.97% | 125.30% |
| Issuance of Common Stock | -- | -- | -100.00% | 17,328.00% | -100.00% |
| Repurchase of Common Stock | -- | -1,900.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.39% | 4.55% | -396.67% | -292.39% | -891.94% |
| Cash from Financing | -90.21% | 83.80% | -112.91% | -98.60% | 124.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 318.89% | 75.88% | -117.44% | 153.02% | 88.39% |